Used primarily in the treatment of osteoporosis, especially in postmenopausal women. It helps reduce the risk of vertebral and hip fractures by promoting bone formation and reducing bone resorption. The compound works by stimulating osteoblast activity while simultaneously inhibiting osteoclast function, leading to an overall increase in bone density. It is taken orally and is considered an option for long-term management of osteoporosis when other treatments are not suitable. However, due to potential cardiovascular risks, its use is generally restricted to patients without a history of heart disease and under strict medical supervision.